| Announce Date | 02/05/2026 |
| EPS Normalized Actual | $1.11 (Miss by $-0.21) |
| EPS GAAP Actual | $1.11 (Miss by $-0.21) |
| Revenue Actual | $0.352674B |
| Revenue Surprise | Beat by $352.674M |
| Announce Date | 03/29/2026 (Pre-Market) |
| EPS Normalized Estimate | $1.685 |
| EPS GAAP Estimate | $1.685 |
| Revenue Estimate | $0.301597B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Sep 2027 | 8.68 | 29.16 | 8.41105 | 8.89073 | 1 |
| Sep 2026 | 5.2 | 48.67 | 5.1765 | 5.22627 | 0 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 8.43 | 8.43 | 0.352674B | 15.35% | 352.67M |
| FQ2 2025 (Jun 2025) | 1.01 | 1.01 | 0.296344B | 12% | 296.34M |
| FQ1 2025 (Mar 2025) | 1.2 | 1.2 | 0.265519B | 6.17% | 265.52M |
| FQ4 2024 (Dec 2024) | 0.91 | 0.91 | 0.247026B | 11.62% | 247.03M |
| FQ3 2024 (Sep 2024) | 1.33 | 1.33 | 0.298533B | 8.67% | 298.53M |
| FQ2 2024 (Jun 2024) | 1.14 | 1.14 | 0.260783B | 4.61% | 260.78M |
| FQ1 2024 (Mar 2024) | 0.9 | 0.9 | 0.249129B | 8.03% | 249.13M |
| FQ4 2023 (Dec 2023) | 0.59 | 0.59 | 0.218314B | 5.87% | 218.31M |
FQ4 Announce Date
03/29/2026 (Pre-Market)
Consensus EPS Estimates
1.685
Consensus Revenue Estimates
0.301597B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ3 2027 (Sep 2027) | 2.615 | -- | 2.46901 | 2.76099 | 1 |
| FQ2 2027 (Jun 2027) | 2.215 | -- | 2.09134 | 2.33866 | 1 |
| FQ1 2027 (Mar 2027) | 1.81 | -- | 1.70895 | 1.91105 | 1 |
| FQ4 2026 (Dec 2026) | 1.5 | -- | 1.41626 | 1.58374 | 1 |
| FQ3 2026 (Sep 2026) | 2.6 | -224.23 | 2.45484 | 2.74516 | 1 |
| FQ2 2026 (Jun 2026) | 2.1 | 51.9 | 1.98276 | 2.21724 | 1 |
| FQ1 2026 (Mar 2026) | 1.685 | 28.78 | 1.64 | 1.73 | 2 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ3 2027 (Sep 2027) | 0.39B | -- | 0.37B | 0.41B | 1 |
| FQ2 2027 (Jun 2027) | 0.35B | -- | 0.34B | 0.37B | 1 |
| FQ1 2027 (Mar 2027) | 0.32B | -- | 0.31B | 0.33B | 1 |
| FQ4 2026 (Dec 2026) | 0.3B | -- | 0.29B | 0.31B | 1 |
| FQ3 2026 (Sep 2026) | 0.38B | 6.72 | 0.36B | 0.39B | 1 |
| FQ2 2026 (Jun 2026) | 0.33B | 10.49 | 0.32B | 0.35B | 1 |
| FQ1 2026 (Mar 2026) | 0.3B | 11.96 | 0.29B | 0.32B | 2 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
8
EPS # of Misses
0
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 8.43 | 8.43 | 100% | |
| FQ2 2025 (Jun 2025) | 1.01 | 1.01 | 100% | |
| FQ1 2025 (Mar 2025) | 1.2 | 1.2 | 100% | |
| FQ4 2024 (Dec 2024) | 0.91 | 0.91 | 100% | |
| FQ3 2024 (Sep 2024) | 1.33 | 1.33 | 100% | |
| FQ2 2024 (Jun 2024) | 1.14 | 1.14 | 100% | |
| FQ1 2024 (Mar 2024) | 0.9 | 0.9 | 100% | |
| FQ4 2023 (Dec 2023) | 0.59 | 0.59 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $0B | $0.35B | $352.67M | 100% |
| FQ2 2025 (Jun 2025) | $0B | $0.3B | $296.34M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $0.27B | $265.52M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $0.25B | $247.03M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $0.3B | $298.53M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $0.26B | $260.78M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $0.25B | $249.13M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $0.22B | $218.31M | 100% |